Corbus Pharma (CRBP) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

Corbus Pharmaceuticals (CRBP) is currently focused on preparing the final stages of trials for its innovative conjugates. The business's environmental strategy is based on the safe recycling of laboratory waste and strict research ethics. This EV/EBITDA chart on GURU.Markets currently shows 0.00, complementing data on the staff of high-caliber scientists who are attracted to the company by flexible working conditions and stock option programs.

CRBP Corbus Pharmaceuticals Holdings, Inc.: Nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 23.11.2025 - 14.11.2026

CRBP (corbuspharma.com): rincian analitis lan laporan miturut indikator

- rega saham lan target rega konsensus:

Kutipan saham Corbus Pharma|CRBP - Konsensus nilai wajar

- indikator kapitalisasi pasar:

Nilai pasar Corbus Pharmaceuticals, Inc.|CRBP - Total Nilai Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Corbus Pharmaceuticals|CRBP - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku corbuspharma.com|CRBP - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Corbus Pharmaceuticals|CRBP - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Corbus Pharmaceuticals Holdings|CRBP - Utang perusahaan|Rasio utang marang kapitalisasi buku Corbus Pharmaceuticals, Inc.|CRBP - Utang jangka dawa|Utang jangka cendhak perusahaan Corbus Pharmaceuticals|Indikator likuiditas cepet corbuspharma.com

- data bathi bisnis lan rasio investasi:

CRBP - Penghasilan resik perusahaan|Bathi mangsa ngarep Corbus Pharmaceuticals|CRBP - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Corbus Pharmaceuticals|CRBP - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Corbus Pharmaceuticals, Inc.|CRBP - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Corbus Pharmaceuticals|CRBP - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan corbuspharma.com|CRBP - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Corbus Pharmaceuticals

- indikator dodolan lan pendapatan:

CRBP - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan Corbus Pharma|CRBP - Rasio rega marang dodolan|Multiplikator forward rega marang pendapatan Corbus Pharmaceuticals, Inc.

Ringkesan analitik perusahaan:CRBP (Corbus Pharma)

Produk asli Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals (CRBP) is investing significant funds into oncology research, anticipating future superprofits from its proprietary therapy. This EV/EBITDA metric correlates the total enterprise value with the business's ability to generate cash flow before taxes and interest. This chart's price action allows for the filtering of speculative noise, revealing actual undervaluation or the risk of capital freeze. A stable trend confirms the resilience of the model amidst high fixed costs.

Analisis pesaing